MedPath

Akcea Therapeutics, Inc.

Akcea Therapeutics, Inc. logo
🇺🇸United States
Ownership
Public, Subsidiary
Established
2014-01-01
Employees
294
Market Cap
-
Website
http://akceatx.com

Clinical Trials

6

Active:4
Completed:1

Trial Phases

2 Phases

Phase 1:4
Phase 2:1

Drug Approvals

3

FDA:1
CANADA:1

Drug Approvals

Tegsedi

Approval Date
Jan 25, 2024
FDA

Clinical Trials

Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials

Phase 1
4 (80.0%)
Phase 2
1 (20.0%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.